Form 4 for UPC Universe Pharmaceuticals INC
Accepted 2026-05-21 16:16:12 ET · period of report 2026-05-07 · accession 0001213900-26-060060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-21 16:16 | 2026-05-07 | UPC | Lai Gang | CEO, Dir, 10% | A - Grant | — | +84.5K | 12.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A ordinary shares, par value US$0.00001 per share | 2026-05-07 | A | A | 71,890 | — | 71,890 | D | — | — | (F1) Represents a grant of ordinary shares under the Issuer's 2026 Equity Incentive Plan, in a transaction exempt under Rule 16b-3, in consideration for past services rendered by the Reporting Person. The grant is subject to the terms of an award agreement entered into by and between the Reporting Person and the Issuer, dated May 5, 2026. |
| 2 | Common | Class B ordinary shares, par value US$0.00001 per share | 2026-05-07 | A | A | 12,610 | — | 12,610 | D | — | — | (F1) Represents a grant of ordinary shares under the Issuer's 2026 Equity Incentive Plan, in a transaction exempt under Rule 16b-3, in consideration for past services rendered by the Reporting Person. The grant is subject to the terms of an award agreement entered into by and between the Reporting Person and the Issuer, dated May 5, 2026. |